Skip to main content

Table 2 Clinical remission characteristics of PsAID < 4 patients

From: Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study

 PsAID < 4PsAID ≥ 4P value
Articular remission, n (%)*53 (52.0)23 (23.5)< 0.001
Skin remission, n (%)*83 (68.0)51 (50.5)< 0.01
MDA, n (%)
 Tender joint count ≤1, n (%)91 (74.6)53 (52.5)< 0.001
 Swollen joint count ≤1, n (%)82 (67.2)70 (69.3)NS
 PASI ≤ 1/Body surface area ≤ 3%, n (%)96 (79.3)78 (78.8)NS
 Patient pain VAS ≤ 1.5, n (%)63 (53.4)7 (7.1)< 0.0001
 Patient global disease activity VAS ≤ 20, n (%)68 (55.7)28 (27.7)< 0.0001
 HAQ ≤ 0.5, n (%)104 (85.2)33 (32.7)< 0.0001
 Tender entheseal points ≤ 199 (81.8)80 (79.2)NS
PASI, mean (SD)1.2 (3.8)1.8 (3.2)NS
HAQ, mean (SD)0.2 (0.3)0.9 (0.6)< 0.001
  1. *According to physicians criteria
  2. MDA minimal disease activity, PASI Psoriasis Area and Severity Index, VAS visual analog scale, HAQ Health Assessment Questionnaire, PsAID Psoriatic Arthritis Impact of Disease, CI confidence intervals